scispace - formally typeset
K

Keiji Fukuda

Researcher at Li Ka Shing Faculty of Medicine, University of Hong Kong

Publications -  99
Citations -  29021

Keiji Fukuda is an academic researcher from Li Ka Shing Faculty of Medicine, University of Hong Kong. The author has contributed to research in topics: Influenza A virus subtype H5N1 & Influenza A virus. The author has an hindex of 46, co-authored 95 publications receiving 27831 citations. Previous affiliations of Keiji Fukuda include United States Department of Agriculture & University of Hong Kong.

Papers
More filters
Journal ArticleDOI

New mechanisms, new worries

TL;DR: Emerging resistance to colistin has troubling implications for patient care among Gram-negative bacteria, in particular, the carbapenemase-producing Enterobacteriaceae (CPE) (see the image).
Journal ArticleDOI

Preparing for pandemic influenza: the need for enhanced surveillance.

TL;DR: The collaborative planning process has been the development of new working relationships and partnerships among several agencies at the state, local and national levels that will improve the collective ability to rapidly investigate and control public health threats in the 21st century.
Journal Article

Surveillance for influenza--United States, 1994-95, 1995-96, and 1996-97 seasons.

TL;DR: The most recent U.S. influenza surveillance data from both active and passive surveillance systems was collected from the Centers for Disease Control and Prevention (CDC) from 1994 through 1997.
Journal ArticleDOI

Naming diseases: First do no harm

TL;DR: The World Health Organization, OIE, and FAO strongly encourage all national, regional, and international stakeholders, including scientists, national authorities, and media, to follow a set of standard best practices for naming new human infectious diseases in the event of the emergence of a new human disease, so that inappropriate disease names do not become established.